New & Innovative AMD Treatments
Age-related macular degeneration (AMD) is the most common cause of vision loss in people over 50. It affects the central portion of the retina called the “macula” which is responsible for detailed,…
Gene therapy Luxturna recommended for public health care coverage
Another hurdle in the process to bring the gene therapy Luxturna to Canadians has been cleared! In the last few weeks, the Canadian Agency for Drugs and Technologies in Health (CADTH) and…
New study shows staggering costs of Inherited Retinal Diseases
Every year, the cost of inherited retinal diseases (IRDs) in Canada is $1.6 billion, a cost largely borne by affected individuals and their families. IRDs, including retinitis pigmentosa, rod-cone dystrophy, and Stargardt…
Eye Health Videos
Fighting Blindness Canada (FBC) has partnered with Accessible Media Inc. (AMI) to produce a series of videos about vision health and a variety of eye diseases, hosted by Dr. Ana Juricic. Dr. Ana…
Looking into the genetics of inherited retinal diseases with Dr. Rob Koenekoop
Meet the Expert: Dr. Robert Koenekoop is a Montreal-based clinician-scientist, meaning he is both a medical doctor, trained in Ophthalmology and also does research about inherited retinal diseases (IRDs). He’s also a…
11 years in the making: Supreme Court of Canada upholds Genetic Non-Discrimination Act (GNDA)
In the past decades, genetic testing has played a growing role in the diagnosis of inherited eye diseases such as retinitis pigmentosa, Usher syndrome and Leber Congenital Amaurosis. Not only can a…
Join the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.
